Financial Information
Stock Information
Press Release




Subject : [AFP] S. Korea approves sales of new stem cell drug
Register : MEDIPOST
View/Date : Hit : 8948, Date : 2012/01/26 20:31

S. Korea approves sales of new stem cell drug

A South Korean researcher holds Cartistem, an allogeneic stem cell
drug developed by Seoul-based Medipost (AFP/Medipost)

SEOUL — South Korea's government drug agency cleared the way Thursday for commercial sales of what it called the world's first approved medicine using stem cells collected from other people.

Cartistem, developed by Seoul-based Medipost, will help regenerate knee cartilage using stem cells developed from newborns' umbilical cord blood, the Korea Food and Drug Administration said.

"Cartistem is... the world's first approved allogeneic (taken from different individuals of the same species) stem cell drug, that can offer new opportunity for treatment of patients with degenerative arthritis," the administration said in a statement.

Medipost said 27 billion won ($23.8 million) from private investors and government funds had been invested to develop Cartistem since 2001. The drug can be injected into a patient's knees via surgery.

Clinical trials have been under way in the United States since last year, the statement said.

Two of the world's top 10 drugmakers are in talks to seek a worldwide licence to make the drug, a Medipost spokesman told AFP, adding that final trials involving a large number of people would likely begin in the US in 2015.


All article: 88,  Current Page: 1/6
No. Subject Register Date View
88 [Press] Medipost will set up a joint venture company in China MEDIPOST 2014/12/09 465
87 [The DONG-A ILBO] Korean stem cells regenerate coach Hiddink's worn-.. MEDIPOST 2014/11/06 330
86 [Press] MEDIPOST, lung disease stem cell treatment drug 'Pneumostem'.. MEDIPOST 2014/08/12 648
85 [Press] MEDIPOST, lung disease stem cell drug designated 'orphan dru.. MEDIPOST 2014/07/29 581
84 [Press] Hiddink, designated MEDIPOST Cord Blood Honorary Ambassador MEDIPOST 2014/07/23 603
83 [Press] MEDIPOST, Stem Cell Drug 'Cartistem' Treatment Japanese Pat.. MEDIPOST 2014/07/10 535
82 [Press] Medipost, US patent for 'CARTISTEM' raw material stem cell d.. MEDIPOST 2014/05/15 939
81 [Press] Medipost, successful administration of stem cell dementia tr.. MEDIPOST 2014/04/28 394
80 [Press] Medipost, Japan patent for dementia treatment technology usi.. MEDIPOST 2014/04/17 389
79 [Press] Medipost, stem cell treatment 'CARTISTEM' patient cutting th.. MEDIPOST 2014/03/27 454
78 [Press] Medipost, Stemcell cartilage differentiation technology Sing.. MEDIPOST 2014/03/18 395
77 [Press]Clinical thesis for lung treatment 'Pneumostem' published in.. MEDIPOST 2014/02/10 92
76 [Press] Football Manager Guus Hiddink, receives arthritis surgery wi.. MEDIPOST 2014/01/09 561
75 [Press] Medipost, designated 'Stem Cell Hair Growth Solution' resear.. MEDIPOST 2013/12/20 531
74 [Press] Medipost, signed license for 'Cartistem' in India MEDIPOST 2013/12/16 633
1 2 3 4 5 6

21, Daewangpangyo-ro 644beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea